Quick and Inexpensive COVID19 HOME Antigen Test. Anyone can perform this test and do not need anything else besides what is provided in the kit.
MONROVIA, CALIFORNIA, UNITED STATES, October 15, 2020 /EINPresswire.com/ — Pace Diagnostics, an emerging California-based biotech startup, is about to initiate a crowd-funding campaign to help launch a novel and sensitive COVID-19 Antigen Rapid Detection Test that will boost the accuracy and the accessibility of COVID-19 testing worldwide. After successfully developing rapid tests for early detection of lung cancer and for tuberculosis, which have advanced to pre-clinical trial stage, the company is ready to take on the challenge of providing COVID-19 Antigen Rapid Detection Test (RDT) to help bring the pandemic under control. The campaign will run for several weeks, with donations used to cover manufacturing, clinical testing, regulatory submission, and deployment once the Company gets the green light. The demand for these COVID-19 Antigen Rapid Detection Tests has been estimated to be ~500 million in 2020-2021. Recent news about Trump’s son (Barron) testing positive for COVID-19 has further confirmed the need for frequent, affordable, and quick diagnostics testing solutions.
More information is available at https://www.pacediagnostics.com/
Like many other U.S. companies, Pace Diagnostics has been fighting a lack of funding as a consequence of the coronavirus pandemic. However, our team has taken on this challenge and uses it as the motivation to launch our breakthrough COVID-19 Antigen RDT. Our COVID-19 Antigen RDT will provide results within 15 minutes and can detect an on-going infection, allowing users to make appropriate healthcare and lifestyle decisions.
Despite hundreds of millions of dollars spent by the U.S. government to deploy Antigen Rapid Detection Tests, not much funding has been made available to highly innovative players like Pace Diagnostics, whose predecessor received several Small Business Innovation Research grants in the last decade. We are turning to the public and the power of community funding for help to launch this test.
“Our objective is to identify the disease cases quickly and accurately so that people can make better healthcare decisions” our CEO, Dr. Hiep-Hoa Nguyen commented. “We design our tests for use both in your home and in the office of your healthcare provider, they can be performed by untrained individuals or by minimally trained personnel, further increasing their reach. Once you know your status, you know exactly what to do.”
For more information on Pace Diagnostics and their biotech research, visit the URL above.
Pace Diagnostics – better diagnostics test for better living
Source: EIN Presswire